Level Chart

Basic Info

Regeneron Pharmaceuticals (REGN) - Net Product Sales Revenue is at a current level of 1.852B, up from 1.786B last quarter and up from 1.699B one year ago. This is a change of 3.68% from last quarter and 8.97% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.852B
Latest Period Dec 2023
Last Updated Feb 2 2024, 17:26 EST
Next Release Apr 30 2024, 08:30 EDT (E)
Average Growth Rate 38.87%
Value from Last Quarter 1.786B
Change from Last Quarter 3.68%
Value from 1 Year Ago 1.699B
Change from 1 Year Ago 8.97%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 1.852B
September 30, 2023 1.786B
June 30, 2023 1.772B
March 31, 2023 1.668B
December 31, 2022 1.699B
September 30, 2022 1.801B
June 30, 2022 1.754B
March 31, 2022 1.639B
December 31, 2021 3.975B
Date Value
September 30, 2021 2.280B
June 30, 2021 4.138B
March 31, 2021 1.724B
December 31, 2020 1.622B
September 30, 2020 1.482B
June 30, 2020 1.227B
March 31, 2020 1.237B
December 31, 2019 1.286B

Basic Info

Regeneron Pharmaceuticals (REGN) - Net Product Sales Revenue is at a current level of 1.852B, up from 1.786B last quarter and up from 1.699B one year ago. This is a change of 3.68% from last quarter and 8.97% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.852B
Latest Period Dec 2023
Last Updated Feb 2 2024, 17:26 EST
Next Release Apr 30 2024, 08:30 EDT (E)
Average Growth Rate 38.87%
Value from Last Quarter 1.786B
Change from Last Quarter 3.68%
Value from 1 Year Ago 1.699B
Change from 1 Year Ago 8.97%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
REGN Regeneron Pharmaceuticals Inc -0.84%